论文部分内容阅读
目的:探讨依布利特及胺碘酮用于心房颤动、心房扑动转复的效果差异。方法:将63例房扑及60例房颤患者各随机分为二组,分别应用依布利特及胺碘酮治疗,转复为有效,未转复为无效。结果:依布利特对于房扑的转复率与胺碘酮对比有统计学意义(76.67%vs.27.27%,P<0.05),但对于房颤的转复依布利特与胺碘酮无差别(66.67%vs.48.15%,P>0.05);因此,依布利特转复房扑的成功率高于房颤。结论:依布利特转复房扑优于胺碘酮,其对房扑的转复成功率高于房颤。
Objective: To investigate the effect of ebuterol and amiodarone on atrial flutter and atrial flutter. Methods: 63 patients with atrial flutter and 60 patients with atrial fibrillation were randomly divided into two groups. They were treated with EbTI and amiodarone, respectively. Results: The recovery rate of atrial flutter in atrial flutter vs amiodarone was statistically significant (76.67% vs.27.27%, P <0.05) There was no difference (66.67% vs.48.15%, P> 0.05). Therefore, the success rate of Ebuterolefus on atrial flutter was higher than that of atrial fibrillation. CONCLUSION: Ebuterole is superior to amiodarone in the recovery of atrial flutter, and its successful rate of atrial flutter recovery is higher than that of atrial fibrillation.